CPMV
Mosaic ImmunoEngineering, Inc.
Price Chart
Latest Quote
$0.67
+0.00 (+0.00%)
Current Price
| Previous Close | $0.67 |
| Open | $0.69 |
| Day High | $0.69 |
| Day Low | $0.69 |
| Volume | 100 |
Stock Information
| Shares Outstanding | 7.24M |
| Total Debt | $1.68M |
| Cash Equivalents | $72 |
| Net Income | $-682K |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $4.88M |
| EPS (TTM) | $-0.09 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $6.57M |
| Income | $-682K |
| Book/sh | $-1.06 |
| Cash/sh | $0.00 |
| Employees | 2 |
Financial Ratios
| Current Ratio | 0.00 |
Returns & Margins
| ROA | -692.47% |
Ownership
| Insider Ownership | 88.68% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| PEG | 0.87 |
| P/B | -0.64 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.64 |
| SMA50 | $0.67 |
| SMA200 | $0.60 |
| RSI | 45.89 |
| ATR | 0.1005 |
| Shares Float | 820K |
| Volatility | -0.79 |
Performance History
| Week | +0.00% |
| Month | -3.02% |
| Quarter | +34.80% |
| 6 Months | +68.50% |
| YTD | +116.72% |
| Year | +104.86% |
| 3 Years | -20.71% |
| 5 Years | -66.30% |
| 10 Years | -66.30% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-17 | $0.67 | 0 |
| 2026-06-16 | $0.67 | 0 |
| 2026-06-15 | $0.67 | 0 |
| 2026-06-12 | $0.67 | 0 |
| 2026-06-11 | $0.67 | 0 |
| 2026-06-10 | $0.67 | 0 |
| 2026-06-09 | $0.67 | 700 |
| 2026-06-08 | $0.67 | 0 |
| 2026-06-05 | $0.67 | 0 |
| 2026-06-04 | $0.67 | 0 |
| 2026-06-03 | $0.67 | 200 |
| 2026-06-02 | $0.33 | 0 |
| 2026-06-01 | $0.33 | 900 |
| 2026-05-29 | $0.39 | 500 |
| 2026-05-28 | $0.74 | 0 |
| 2026-05-27 | $0.74 | 0 |
| 2026-05-26 | $0.74 | 4,700 |
| 2026-05-22 | $0.69 | 0 |
| 2026-05-21 | $0.69 | 0 |
| 2026-05-20 | $0.69 | 0 |
| 2026-05-19 | $0.69 | 0 |
| 2026-05-18 | $0.69 | 0 |
About Mosaic ImmunoEngineering, Inc.
Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer. The company engages in pursuing new product candidates and platforms to build a pipeline based on immunotherapies. Mosaic ImmunoEngineering, Inc. was founded in 2020 and is based in Huntington Beach, California.
đ° Latest News
No news articles available at the moment. Check back later for updates on CPMV.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $81,933 | $89,175 | $151,581 | $160,148 |
| Total Expenses | $879,655 | $1,399,768 | $2,627,522 | $3,501,166 |
| Other Income Expense | $42,000 | $479,700 | $400,600 | $-20,800 |
| Other Non Operating Income Expenses | $42,000 | $433,000 | $343,000 | - |
| Net Non Operating Interest Income Expense | $-81,928 | $-85,767 | $-151,548 | $-160,112 |
| Interest Expense Non Operating | $81,933 | $89,175 | $151,581 | $160,148 |
| Operating Expense | $879,655 | $1,399,768 | $2,627,522 | $3,501,166 |
| General And Administrative Expense | $695,788 | $964,319 | $1,579,065 | $2,045,047 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-921,983 | $-1,008,235 | $-2,380,870 | $-3,684,478 |
| Net Interest Income | $-81,928 | $-85,767 | $-151,548 | $-160,112 |
| Interest Income | $5 | $3,408 | $33 | $36 |
| Normalized Income | $-921,983 | $-1,045,128 | $-2,426,374 | $-3,669,294 |
| Net Income From Continuing And Discontinued Operation | $-921,983 | $-1,008,235 | $-2,380,870 | $-3,684,478 |
| Total Operating Income As Reported | $-879,655 | $-1,399,768 | $-2,627,522 | $-3,501,166 |
| Net Income Common Stockholders | $-921,983 | $-1,008,235 | $-2,380,870 | $-3,684,478 |
| Net Income | $-921,983 | $-1,008,235 | $-2,380,870 | $-3,684,478 |
| Net Income Including Noncontrolling Interests | $-921,983 | $-1,008,235 | $-2,380,870 | $-3,684,478 |
| Net Income Continuous Operations | $-921,983 | $-1,008,235 | $-2,380,870 | $-3,684,478 |
| Pretax Income | $-919,583 | $-1,005,835 | $-2,378,470 | $-3,682,078 |
| Interest Income Non Operating | $5 | $3,408 | $33 | $36 |
| Operating Income | $-879,655 | $-1,399,768 | $-2,627,522 | $-3,501,166 |
| Earnings From Equity Interest | - | - | - | $0 |
| Per Share | ||||
| Diluted EPS | $-0.13 | $-0.14 | $-0.33 | $-0.55 |
| Basic EPS | $-0.13 | $-0.14 | $-0.33 | $-0.55 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $9,807 | $12,096 | $-5,616 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-837,650 | $-963,360 | $-2,284,489 | $-3,501,130 |
| EBITDA (Bullshit earnings) | $-837,650 | $-916,660 | $-2,226,889 | $-3,521,930 |
| EBIT | $-837,650 | $-916,660 | $-2,226,889 | $-3,521,930 |
| Diluted Average Shares | $7,236,447 | $7,236,447 | $7,235,609 | $6,712,675 |
| Basic Average Shares | $7,236,447 | $7,236,447 | $7,235,609 | $6,712,675 |
| Diluted NI Availto Com Stockholders | $-921,983 | $-1,008,235 | $-2,380,870 | $-3,684,478 |
| Tax Provision | $2,400 | $2,400 | $2,400 | $2,400 |
| Research And Development | $183,867 | $435,449 | $1,048,457 | $1,456,119 |
| Selling General And Administration | $695,788 | $964,319 | $1,579,065 | $2,045,047 |
| Other Gand A | $695,788 | $964,319 | $1,579,065 | $2,045,047 |
| Total Unusual Items | - | $46,700 | $57,600 | $-20,800 |
| Total Unusual Items Excluding Goodwill | - | $46,700 | $57,600 | $-20,800 |
| Gain On Sale Of Security | - | $46,700 | $57,600 | $-20,800 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-6,788,174 | $-5,871,058 | $-4,884,758 | $-2,799,011 |
| Total Assets | $141,611 | $179,533 | $261,277 | $269,494 |
| Total Non Current Assets | $0 | $0 | $0 | $0 |
| Current Assets | $141,611 | $179,533 | $261,277 | $269,494 |
| Other Current Assets | $26,592 | $23,355 | $40,632 | $43,352 |
| Cash Cash Equivalents And Short Term Investments | $115,019 | $156,178 | $220,645 | $226,142 |
| Cash And Cash Equivalents | $115,019 | $156,178 | $220,645 | $226,142 |
| Prepaid Assets | - | - | - | $43,352 |
| Receivables | - | - | - | $0 |
| Taxes Receivable | - | - | - | $0 |
| Debt | ||||
| Net Debt | $1,477,496 | $1,161,358 | $1,007,716 | $509,006 |
| Total Debt | $1,592,515 | $1,317,536 | $1,228,361 | $735,148 |
| Long Term Debt And Capital Lease Obligation | $1,392,515 | $1,317,536 | $1,228,361 | $735,148 |
| Long Term Debt | $1,392,515 | $1,317,536 | $1,228,361 | $735,148 |
| Current Debt And Capital Lease Obligation | $200,000 | - | - | - |
| Current Debt | $200,000 | - | - | - |
| Other Current Borrowings | $200,000 | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $6,929,785 | $6,050,591 | $5,146,035 | $3,068,505 |
| Total Non Current Liabilities Net Minority Interest | $1,392,515 | $1,317,536 | $1,228,361 | $735,148 |
| Current Liabilities | $5,537,270 | $4,733,055 | $3,917,674 | $2,333,357 |
| Other Current Liabilities | $177,244 | $177,244 | $223,944 | $281,544 |
| Payables And Accrued Expenses | $1,392,374 | $1,370,900 | $1,294,598 | $660,516 |
| Payables | $134,865 | $118,478 | $133,464 | $113,513 |
| Accounts Payable | $134,865 | $118,478 | $133,464 | $113,513 |
| Equity | ||||
| Common Stock Equity | $-6,788,175 | $-5,871,059 | $-4,884,759 | $-2,799,012 |
| Preferred Stock Equity | $1 | $1 | $1 | $1 |
| Total Equity Gross Minority Interest | $-6,788,174 | $-5,871,058 | $-4,884,758 | $-2,799,011 |
| Stockholders Equity | $-6,788,174 | $-5,871,058 | $-4,884,758 | $-2,799,011 |
| Retained Earnings | $-8,838,320 | $-7,916,337 | $-6,908,102 | $-4,527,232 |
| Other | ||||
| Ordinary Shares Number | $7,242,137 | $7,242,137 | $7,242,137 | $7,241,137 |
| Share Issued | $7,242,137 | $7,242,137 | $7,242,137 | $7,241,137 |
| Tangible Book Value | $-6,788,175 | $-5,871,059 | $-4,884,759 | $-2,799,012 |
| Invested Capital | $-5,195,660 | $-4,553,523 | $-3,656,398 | $-2,063,864 |
| Working Capital | $-5,395,659 | $-4,553,522 | $-3,656,397 | $-2,063,863 |
| Total Capitalization | $-5,395,659 | $-4,553,522 | $-3,656,397 | $-2,063,863 |
| Additional Paid In Capital | $2,050,073 | $2,045,206 | $2,023,271 | $1,728,148 |
| Capital Stock | $73 | $73 | $73 | $73 |
| Common Stock | $72 | $72 | $72 | $72 |
| Preferred Stock | $1 | $1 | $1 | $1 |
| Pensionand Other Post Retirement Benefit Plans Current | $3,767,652 | $3,184,911 | $2,399,132 | $1,391,297 |
| Current Accrued Expenses | $1,257,509 | $1,252,422 | $1,161,134 | $547,003 |
| Other Short Term Investments | - | - | - | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-241,159 | $-497,467 | $-690,129 | $-679,236 |
| Operating Activities | ||||
| Operating Cash Flow | $-241,159 | $-497,467 | $-690,129 | $-679,236 |
| Cash Flow From Continuing Operating Activities | $-241,159 | $-497,467 | $-690,129 | $-679,236 |
| Operating Gains Losses | - | $-479,700 | $-400,600 | $20,800 |
| Investing Activities | ||||
| Investing Cash Flow | $0 | $433,000 | $343,000 | $27,637 |
| Cash Flow From Continuing Investing Activities | $0 | $433,000 | $343,000 | $27,637 |
| Net Other Investing Changes | - | $433,000 | $343,000 | - |
| Financing Activities | ||||
| Financing Cash Flow | $200,000 | $0 | $341,632 | $525,003 |
| Cash Flow From Continuing Financing Activities | $200,000 | $0 | $341,632 | $525,003 |
| Issuance Of Capital Stock | - | - | - | $0 |
| Net Common Stock Issuance | - | - | - | $0 |
| Common Stock Issuance | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-70,000 | $0 | - | - |
| Issuance Of Debt | $270,000 | $0 | $341,632 | $525,003 |
| Income Tax Paid Supplemental Data | $2,400 | $2,400 | $2,400 | $2,400 |
| End Cash Position | $115,019 | $156,178 | $220,645 | $226,142 |
| Beginning Cash Position | $156,178 | $220,645 | $226,142 | $352,738 |
| Changes In Cash | $-41,159 | $-64,467 | $-5,497 | $-126,596 |
| Net Issuance Payments Of Debt | $200,000 | $0 | $341,632 | $525,003 |
| Net Short Term Debt Issuance | $200,000 | $0 | - | - |
| Short Term Debt Payments | $-70,000 | $0 | - | - |
| Short Term Debt Issuance | $270,000 | $0 | - | - |
| Change In Working Capital | $600,978 | $879,358 | $1,644,637 | $1,516,286 |
| Change In Other Working Capital | $582,741 | $785,779 | $1,007,835 | $26,078 |
| Change In Payables And Accrued Expense | $604,215 | $862,081 | $1,641,917 | $1,482,211 |
| Change In Accrued Expense | $587,828 | $877,067 | $1,621,966 | $1,454,712 |
| Change In Payable | $16,387 | $-14,986 | $19,951 | $27,499 |
| Change In Account Payable | $16,387 | $-14,986 | $19,951 | $27,499 |
| Change In Prepaid Assets | $-3,237 | $17,277 | $2,720 | $7,997 |
| Other Non Cash Items | $74,979 | $89,175 | $151,581 | $160,148 |
| Stock Based Compensation | $4,867 | $21,935 | $295,123 | $1,308,008 |
| Net Income From Continuing Operations | $-921,983 | $-1,008,235 | $-2,380,870 | $-3,684,478 |
| Interest Paid Supplemental Data | - | $0 | $0 | $0 |
| Net Long Term Debt Issuance | - | $0 | $341,632 | $525,003 |
| Long Term Debt Issuance | - | $0 | $341,632 | $525,003 |
| Gain Loss On Investment Securities | - | $-479,700 | $-400,600 | $20,800 |
| Net Business Purchase And Sale | - | - | $0 | $27,637 |
| Sale Of Business | - | - | $0 | $27,637 |
| Earnings Losses From Equity Investments | - | - | - | $0 |
Fetched: 2026-02-02